What does the evidence say about Garlic Cholesterol Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Garlic Cholesterol Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Also, total cholesterol (TC) was significantly reduced (WMD: -8.26; 95% CI: -14.65 to -1.88; I ² = 90.9%) based on 7 effect sizes, while changes in HDL-C, TG, and LDL-C were not significant overall. [Ebrahimzadeh A (2026); evidence level 1] - Moreover, longer duration of garlic supplementation significantly improved all lipid profiles in patients with T2DM. [Ebrahimzadeh A (2026); evidence level 1] - Background Garlic, as an additive, a spice, and an ancient herbal medicine, has been proposed as a potential treatment for type 2 diabetes mellitus (T2DM). [Ebrahimzadeh A (2026); evidence level 1] - This systematic review and meta-analysis provides a comprehensive evaluation of the effects of garlic supplementation on fasting blood sugar (FBS), hemoglobin A1c (HbA1c), and lipid profile in patients with T2DM. [Ebrahimzadeh A (2026); evidence level 1] - Background Hypercholesterolemia is a significant risk factor for cardiovascular diseases, necessitating effective management strategies. [Aravind A (2025); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.